These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intermittent hypoxia increases ROS/HIF-1α 'related oxidative stress and inflammation and worsens bleomycin-induced pulmonary fibrosis in adult male C57BL/6J mice. Xiong M; Zhao Y; Mo H; Yang H; Yue F; Hu K Int Immunopharmacol; 2021 Nov; 100():108165. PubMed ID: 34560512 [TBL] [Abstract][Full Text] [Related]
7. Deregulated immune cell recruitment orchestrated by c-MET impairs pulmonary inflammation and fibrosis. Barbosa-Matos C; Borges-Pereira C; Libório-Ramos S; Fernandes R; Oliveira M; Mendes-Frias A; Silvestre R; Osório NS; Bastos HN; Santos RF; Guimarães S; Morais A; Mazzone M; Carvalho A; Cunha C; Costa S Respir Res; 2024 Jun; 25(1):257. PubMed ID: 38909206 [TBL] [Abstract][Full Text] [Related]
8. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice. Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE Respiration; 2018; 95(2):122-136. PubMed ID: 29131071 [TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis. Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656 [TBL] [Abstract][Full Text] [Related]
10. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
11. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Ortiz LA; Lasky J; Hamilton RF; Holian A; Hoyle GW; Banks W; Peschon JJ; Brody AR; Lungarella G; Friedman M Exp Lung Res; 1998; 24(6):721-43. PubMed ID: 9839161 [TBL] [Abstract][Full Text] [Related]
12. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891 [TBL] [Abstract][Full Text] [Related]
17. Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis. Banerjee ER; Henderson WR Stem Cell Res Ther; 2012 May; 3(3):21. PubMed ID: 22643035 [TBL] [Abstract][Full Text] [Related]
18. NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis. Liu CP; Kuo MS; Wu BN; Chai CY; Huang HT; Chung PW; Chen IJ Pulm Pharmacol Ther; 2014 Feb; 27(1):17-28. PubMed ID: 23518214 [TBL] [Abstract][Full Text] [Related]
19. Bleomycin-induced pulmonary fibrosis is independent of eosinophils. Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973 [TBL] [Abstract][Full Text] [Related]
20. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice]. Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]